Publicação científica trimestral do CREMERJ - número 3 - 2022

92 Doença associada à infecção pelo Clostridioides difficile . Atualização Nelson Gonçalves Pereira et al. Med. Ciên. e Arte , Rio de Janeiro, v.1, n.3, p.49-93, jul-set 2022 29. Lamont T, Bakken J & Kelly CP. Clostridioides difficile infection in adults: Epidemiology, Microbiology and Pathophisiology. In UPTODATE, 2021 acessado em 13/12/2021. 30. Mc Donald LC et al. Clinical Practice Guidelines for Clostridium difficile Infection in Adults and Children: 2017 UPDATE BY THE Infectious Diseases Society of America (IDSA) and Society for Healthcare Epidemiology of America (SHEA), Cli Inf Dis, 2018: 66(7):e1-e48. 31. Sartelli M, et al. 2019 update of the WSES guidelines for Management of Clostridioides difficile infection of surgical patients World Journal of Emergency Surgery (2019): 14(8):1-29. 32. Khanna S & Gerding DN. Current and future trends. In Clostridioides (Clostridium) difficile infection management. Anaerobe 2019; 58:95-102. 33. Gateau C, Couturier J, Cola J & Barbut F. How to: Diagnose Infection caused by Clostridium difficile. Clinical Microbiology and Infection 24 (2018):463-468. 34. Somely AM, Khan MA & Morshed M. The laboratory diagnosis of current laboratory practice. J Infect Dis Ctries, 2021; 15(10):1364-1375. 35. Spanish Society of Chemotherapy. Recomendationes for the diagnosis and treatment of Clostridioides difficile infection: an official clinical practice guideline of the Spanisa Society of Chemotherapy (SEC) Spanish Society of Internal Medicine (SEMI) and the working group of Postoperative Infection of the Spanish Society of A nesthesia and Reanimation (SEDAR). Rev Esp Chimioter, 2020: 33 (2):151-175. 36. Kelly CR, et al. ACG clinical guidelines: Prevention, Diagnosis and treatment of Clostridioides difficile infection. Am J Gastroenterol 2021; 116:1124-1147. 37. Bouza E, et al. Recommendations for diagnosis and treatment of Clostridioides difficile infection; an official clinical practice guideline of the Spanish Society Chemotherapy (SEQ), Spanish Society of Internal Medicine (SEMI) and working group of postoperative infection of the Spanish Society of Anesthesia and Reanimation (SEDAR) Rev Esp Quimioter 2020: 33(2):151-172. 38. Loo VG, et al. Association of Medical Microbiology and Infectious Diseases Canada Treatment practice Guidelines of Clostridium difficile Infection. Official Journal of the Association of Medical Microbiology and Infectious Disease Canada 2018, Vol. 3, No. 2, pp. 71-92. 39. Martins CS. Alterações induzidas pela toxina A do Clostridioides difficile na via WNT/betacatenina in vivo e papel do RAC-1 na sua inicição em células epiteliais intestinais. Tese de doutorado apresentada no Curso de Pós-graduação em Ciências morfofuncionais, Universidade do Ceará, 2018. 40. Kelly CP, Lamont T & Bakken JS. Clostridium difficile infection in adults: treatment and Prevention. 2021 In UPTODATE, acessado em 13/12/2021. 41. Surawicz CM, Brandt LJ, Binion DG, Ananthakrishnan AN, Curry SR, Giligan PH, Mc Farland LV, MellowM& Zuckerbraun BS. Guidelines for diagnosis, treatment, and prevention of Clostridium difficile infections. The Am J Gastroenterol (2013) 108: 478-498. 42. Lamont JT, Kelly CP & Bakken SJ. Clostridioides difficile infrection in adults. Clinical manifestations and diagnosis, In UPTODATE 2021, acessado em 18/12/2021. 43. Keller JM & Surawicz CM. Clostridium difficile infection in elderly. Cli Geriatr Med (2014), 30:79-93. 44. Tavares W. “Fármacos antiprotozoarias", cap 26, p. 501, e "Glicopeptideos e Lipopeptideos", Cap 16, p. 352, In Antibióticos e Quimioterápicos para o Clínico, quarta edição, Tavares W, Editora Atheneu, Rio de Janeiro, 2020 45. Crews J. Clostridioides difficile Infection in Children: treatment and Outcome. UPTODATE, 2021, acessado em 13/12/2021. 46. Bass SN, Lam SW, Bauer SR & Neuner EA. Comparison of oral vancomycin capsule and solution for treatment of initial epizode of severe Clostridium difficile infection. J PharmPract (2013), epub ahead of print, Dec 27. 47. Scott LJ. Fidaxomicin: a review of its use in Patients with Clostridium difficile infection. Drugs (2013) 73:1733-1747.